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Abstract
The early growth response gene 2 (EGR2) is located at 
chromosome 10q21, one of the susceptibility loci in bi-
polar disorder (BD). EGR2 is involved in cognitive func-
tion, myelination, and signal transduction related to 
neuregulin-ErbB receptor, Bcl-2 family proteins, and 
brain-derived neurotrophic factor. This study inves-
tigated the genetic association of the EGR2 gene with 
BD and schizophrenia (SPR) in Korea. In 946 subjects 
(350 healthy controls, 352 patients with BD, and 244 
with  SPR),  nine  single  nucleotide  polymorphisms 
(SNPs) in the EGR2 gene region were genotyped. Five 
SNPs showed nominally significant allelic associa-
tions with BD (rs2295814, rs61865882, rs10995315, 
rs2297488, and rs2297489), and the positive associa-
tions of all except rs2297488 remained significant after 
multiple testing correction. Linkage disequilibrium 
structure  analysis  revealed  two  haplotype  blocks. 
Among the common identified haplotypes (frequency 
＞ 5%), 'T-G-A-C-T (block 1)' and 'A-A-G-C (block 2)' 
haplotypes were over-represented, while 'C-G-G-T-T 
(block 1)' haplotype was under-represented in BD. In 
contrast, no significant associations were found with 
SPR. Although an extended analysis with a larger sam-
ple size or independent replication is required, these 
findings suggest a genetic association of EGR2 with 
BD. Combined with a plausible biological function of 
EGR2, the EGR2 gene is a possible susceptibility gene 
in BD.
Keywords: bipolar disorder; EGR2 protein, human; 
genes, immediate early; genetic association studies; 
schizophrenia 
Introduction
Early growth response (EGR) genes, which include 
EGR1,  EGR2,  EGR3, and EGR4, encode DNA- 
binding transcription factors that contain cys2-his2 
zinc fingers (Beckmann and Wilce, 1997; O’Donovan 
et al., 1999). The EGR genes encode a family of 
immediate early gene transcription factors that 
mediate the transcription of various genes related 
to neuronal development and plasticity, cognition, 
circadian rhythm, and social behaviors (Beckmann 
and Wilce, 1997; Morris et al., 1998; O’Donovan et 
al., 1999; Davis et al., 2003; Knapska and 
Kaczmarek, 2004; James et al., 2006; Baumgartel 
et al., 2008; Poirier et al., 2008), which have been 
implicated in the pathophysiology of schizophrenia 
(SPR) and bipolar disorder (BD). EGRs  are 
involved in rodent models of psychotic disorders 122    Exp. Mol. Med. Vol. 44(2), 121-129, 2012
(Gallitano-Mendel et al., 2007, 2008), as well as in 
the action mechanisms of antipsychotics and 
electroconvulsive seizures (Yamagata et al., 1994; 
Jung et al., 1996; Verma et al., 2007).
    Moreover, downregulation of EGR1, EGR2, and 
EGR3  transcripts in the postmortem brains of 
patients with SPR has been reported (Yamada et 
al., 2007). In particular, EGR3 has a strong, consis-
tent association with SPR in both family-based and 
case-control association studies in Japanese 
cohorts (Yamada et al., 2007). We replicated this in 
an independent association study in Korea (Kim et 
al., 2010b), while a negative association has been 
reported in a Chinese population (Liu et al., 2010). 
Additionally, a genetic association between EGR3 
and bipolar disorder was recently reported (Mansour 
et al., 2009).
    Although EGRs encode closely related transcrip-
tion factors that contain cys2-his2 zinc fingers that 
can bind to the same cognate GC-rich consensus 
DNA binding motif, individual EGR  genes have 
little sequence homology outside the common 
DNA-binding domain. Furthermore, they are re-
gulated by different signal pathways and serve 
different functions (Beckmann and Wilce, 1997; 
Herdegen and Leah, 1998; Poirier et al., 2008). In 
certain circumstances, they may even have 
antagonistic functions; for example, Egr1 and Egr2 
exert opposing influences on adipocyte differentia-
tion (Boyle et al., 2009) and T cell receptor-induced 
changes in T cell function (Collins et al., 2008). 
Additionally,  Egr2  has been reported to have 
different effects on cognitive function than other 
Egr genes (Poirier et al., 2007).
    The human EGR2 gene resides at chromosomal 
location 10q21.3, which the linkage analysis has 
identified as a susceptibility locus for BD (Venken 
et al., 2008). The linked regions could contain 
multiple susceptibility genes showing association 
(Straub and Weinberger, 2006). For example, 
ankyrin G (ANK3), one of the most promising 
susceptibility genes for BD, is also located at 
chromosome 10q21 (Ferreira et al., 2008; Schulze 
et al., 2009; Smith et al., 2009). On the other hand, 
Egr2 is involved in regulating Bcl-2 family protein 
and mitochondrial function (Unoki and Nakamura, 
2003; Lauritsen et al., 2008), which are thought to 
be involved in the pathophysiology of BD (Kato, 
2006; Marmol, 2008; Andreazza et al., 2010; Kim 
et al., 2010a). These findings suggest the possible 
involvement of EGR2 in BD.
    EGR2 plays important roles in peripheral nerve 
myelination, T cell maturation, hindbrain segmenta-
tion, and lipid biosynthesis (Schneider-Maunoury et 
al., 1993; Swiatek and Gridley, 1993; Topilko et al., 
1994; Leblanc et al., 2005). As noted above, the 
involvement of Egr2 in cognitive behavioral pheno-
types have been reported. An attention set shifting 
task induced the expression of Egr2, but not Egr1 
or Egr3, in the frontal cortex of mice (DeSteno and 
Schmauss, 2008). Forebrain-specific Egr2-defi-
cient mice demonstrated enhanced long-term 
object recognition memory and superior implicit 
motor skill learning abilities (Poirier et al., 2007), in 
sharp contrast to the behavioral phenotypes of 
Egr3-deficient mice, which had poor long- and 
short-term memory (Gallitano-Mendel et al., 2007). 
These findings suggest that EGR2  has different 
effects of on brain functions than other EGR 
genes.
    Given the possible relationship between EGR2 
and BD, we investigated the association of EGR2 
with BD in a Korean population. We also extended 
the investigation to the association of EGR2 with 
SPR, which showed negative associations in 
previous Korean and Chinese case control asso-
ciation studies (Kim et al., 2010b; Liu et al., 2010) 
and positive findings in a family-based association 
study done in Japanes population (Yamada et al., 
2007).
Results
Nine SNPs within the 15-kb region surrounding the 
EGR2 gene were selected as described in Methods. 
SNP information, including the relative location of 
the SNPs on the EGR2 gene, is presented in Figure 
1. Of the nine investigated SNPs of EGR2, 
rs2295814 (SNP3), rs61865882 (SNP4), rs10995315 
(SNP6), rs2297488 (SNP7), and rs2297489 (SNP8) 
showed significant allelic associations with BD (P
=0.0027, 0.0008, 0.0020, 0.0103, and 0.0011 for 
each SNP, respectively). These SNPs also showed 
genotypic associations with BD (P =0.0026, 0.0011, 
0.0068, 0.0240, and 0.0048 for each SNP, re-
spectively). The frequencies of the A, C, A, A, and 
G alleles in SNP 3, 4, 6, 7, and 8, respectively, were 
significantly increased in the BD group compared 
to the controls, and all withstood multiple testing 
correction with 10,000 permutations (Ppermutation=
0.0164, 0.0056, 0.0127, 0.0460, and 0.0074 for 
each SNP, respectively). Additionally, the positive 
associations with BD in SNP 3, 4, 6, and 8 re-
mained significant after the Bonferroni correction (P
＜0.0028). The other four SNPs of EGR2 [rs9990 
(SNP1), rs1509963 (SNP2), rs45602133 (SNP5), 
and rs224278 (SNP9)] did not show significant as-
sociations with BD in allele-wise or genotype-wise 
analyses. Additionally, no significant association 
was found between the examined EGR2 SNPs and 
the SPR group. Association results for rs2295814 EGR2 and bipolar disorder    123
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Figure 1. Location of the SNPs on the EGR2 gene and the linkage dis-
equilibrium structure of the locus. Graphic representation of the genomic 
structure and location of the EGR2 SNP sites examined and the linkage 
disequilibrium (LD) structure of the EGR2 haplotype block. Exons are de-
noted by boxes, with untranslated regions in white and translated regions 
in gray. The LD between SNPs was analyzed using the pair-wise LD 
measures D' and r
2 and the haplotype block was constructed using the 
solid spine haplotype algorithm (D' ＞ 0.8). Each diamond either repre-
sents the D' or r
2 measure of LD (D': darker shades of red represent 
greater D' values, r
2: darker shades of black represent greater r
2 values).
Block 1
Marker Frequency
OR χ
2 P
rs9990 rs1509963 rs2295814 rs61865882 rs45602133 Case Control
C G G T T 0.509 0.563 0.805  4.126  0.0422 
T A G T T 0.221 0.227 0.966  0.075  0.7843 
T A G T G 0.107 0.105 1.021  0.017  0.8973 
TGA CT 　 0.114 0.069 1.736  8.548  0.0035
Block 2
Marker Frequency
OR χ
2 P
rs10995315 rs2297488 rs2297489 rs224278 - Case Control
G G C T - 0.658 0.696 0.840  2.290  0.1302 
G G C C - 0.182 0.204 0.868  1.171  0.2792 
AAGC- 　 0.138 0.094 1.543  6.807  0.0091 
The common haplotypes (frequency ＞ 5%) are shown with significant P-values in bold.
Table 2.  Analysis of common haplotypes of the EGR2 gene in the patients with BD
and rs2297488 with the SPR group from our pre-
vious study (Kim et al., 2010b) are included here. 
The genotypic distributions of all SNPs were found 
to be in Hardy-Weinberg equilibrium (HWE) in the 
control, BD, and SPR groups. The allelic and genotypic 
frequencies of the nine SNPs of EGR2 in the three 
groups are summarized in Table 1.
    The linkage disequilibrium (LD) among the nine 
SNPs was investigated. Pair-wise marker LD 
statistics were determined using Haploview. High 
levels of LD between SNPs 2 and 3, and among 
SNPs 6, 7, and 8 were found, as reflected by the 
squared correlation coefficients (r
2), for the SNPs 
that showed significant positive associations with 
BD. The LD block structure was calculated using 
the solid spine method (D' ＞0.8) implemented 
within Haploview, which demonstrated that five 
SNPs (SNPs 1 to 5) and the remaining four SNPs 
(SNPs 6 to 9) formed distinct haplotype blocks 
(blocks 1 and 2). The LD pattern of EGR2 is pre-
sented in Figure 1.
        We performed a haplotype analysis of the 
haplotype blocks formed by the LD structure of the 
EGR2 gene. Regarding haplotype block 1, four 
common haplotypes (frequency ＞5%) were 
analyzed and the ‘C-G-G-T-T (SNP1-5)’ haplotype 
was significantly under-represented (P = 0.0422, χ
2 
=4.126, OR=0.805), while the 'T-G-A-C-T' haplo-
type was significantly over-represented (P =
0.0035,  χ
2 =8.548, OR =1.736) in the BD group 
compared with the controls. Additionally, among 
the three common haplotypes (frequency ＞5%) of 
haplotype block 2, the ‘A-A-G-C (SNP5-8)’ haplo-
type was significantly over-represented in the BD 
group compared to the controls (P =0.0091, χ
2 =
6.807, OR =1.543). The haplotype association with 
BD was consistent with the allelic association 
findings. However, there was no significant haplo-
typic association with the SPR group (data not EGR2 and bipolar disorder    125
shown). The frequencies of the EGR2 haplotypes 
in the control and BD groups are summarized in 
Table 2.
Discussion
In this study, we found a genetic association 
between EGR2 and BD in Korea. Of the nine EGR2 
SNPs examined, five [SNP3 (rs2295814), SNP4 
(rs61865882), SNP6 (rs10995315), SNP7 (rs2297-
488), and SNP8 (rs2297489)] showed significant 
allelic and genotypic associations with BD. 
Additionally, the ‘T-G-A-C-T (SNP1-5)’ and ‘A-A- 
G-C (SNP6-9)’ haplotypes were over-represented, 
while the ‘C-G-G-T-T (SNP1-5)’ haplotype was 
under-represented in the BD subjects. In contrast, 
there was no association between the examined 
SNPs of EGR2 and SPR. These findings provide 
provisional evidence that EGR2 may be a suscep-
tibility gene for BD.
        To our knowledge, this is the first report of a 
positive association of EGR2 with BD. Five SNPs 
in the EGR2 gene, which showed a LD trend, were 
found to be associated with BD. Significant positive 
associations of four EGR2 SNPs (SNPs 3, 4, 6, 
and 8) remained after the multiple testing correc-
tion with permutation analysis and the Bonferroni 
correction. Minor alleles of the associated SNPs, 
A, C, A, A, G in SNP 3, 4, 6, 7, and 8, respectively, 
were over-represented in the BD group. Consis-
tently, the haplotypes containing these alleles, 
‘T-G-A-C-T (SNP1-5)’ in haplotype block 1 and 
‘A-A-G-C (SNP6-9)’ in haplotype block 2, were 
significantly over-represented in the BD group. 
Although an extended analysis with a larger 
sample size or independent replication is required, 
these findings suggest that EGR2 may be related 
to the development of BD.
    Of the associated EGR2 SNPs, SNPs 7 and 8 
(rs2297488 and rs2297489) are located on intron1 
of EGR2. EGR2 expression is upregulated through 
intronic CpG islands methylation (Unoki and 
Nakamura, 2003), and the binding of methyl-CpG- 
binding protein 2 (MeCP2), which plays important 
roles in neurodevelopment (Gonzales and LaSalle, 
2010), to this region upregulates EGR2 expression 
(Swanberg et al., 2009). The C/G polymorphism in 
SNP8 is associated with a sequence change from 
CC to CG [5'-CCACC(C/G)CCATC-3'], which can 
add a CpG site for methylation. Changes in nucleo-
tide sequences related to polymorphisms creating 
additional CpG sites can affect the DNA methyla-
tion and transcriptional activity (Moser et al., 2009). 
These findings suggest a possible function of 
BD-associated intronic SNPs of EGR2 regulating 
gene expression via alterations in DNA methyla-
tion, which requires further examination.
    In  the  central  nervous  system  (CNS),  Egr2 
expression is abundant in neurons (Herdegen et 
al., 1993), and it is expressed strongly in layers II 
and III of the cortical regions of the brain 
(Beckmann and Wilce, 1997), where the reduction 
in neuronal density is most prominent in the 
postmortem brains of patients with mood disorders 
(Rajkowska, 2000). Forebrain-specific knockout of 
Egr2 in mice induced enhanced motor skill learning 
and long-term memory, indicating an inhibitory role 
of Egr2 in certain cognitive functions (Poirier et al., 
2007, 2008). Egr2  is induced in the prefrontal 
cortex of mice performing attention set- shifting 
(DeSteno and Schmauss, 2008), dysfunction of 
which has been implicated as an endophenotype 
of BD (Clark et al., 2005). Egr2 is also involved in 
Nmethyl D-aspartate (NMDA) receptor-mediated 
long-term potentiation (LTP) and long-term 
depression (LTD) in the mouse hippocampus 
(Coba  et al., 2008). These findings suggest the 
involvement of EGR2 dysregulation in the cognitive 
dysfunction of BD through altered levels in the 
brain.
    The function of Egr2 as an intracellular signaling 
molecule supports its potential role in BD. Egr2 is 
involved in the signal pathways possibly responsi-
ble for the pathogenesis of psychotic disorders, 
such as SPR and BD, including intracellular signal 
transduction related to the neuregulin-ErbB recep-
tor (Jacobson et al., 2004; He et al., 2010), calci-
neurin (Hildeman et al., 2003; Kao et al., 2009), 
and brain-derived neurotrophic factor (Glorioso et 
al., 2006). Neuregulin 1 (NRG1) gene has been 
reported to be associated with SPR and BD 
(Stefansson  et al., 2002, 2003; Cassidy et al., 
2006; Thomson et al., 2007; Georgieva et al., 
2008). Egr2 acts as a downstream effector of the 
neuregulin-ErbB receptor signal, which plays a 
critical role in peripheral nerve myelination in 
Schwann cells (Kao et al., 2009; He et al., 2010). 
In the CNS, a different role of the neuregulin signal 
in brain development has been suggested, such as 
guiding axon pathfinding (Birchmeier, 2009). These 
findings suggest a different role of Egr2 in the CNS 
as a downstream effector of neuregulin signals, 
which requires further investigation. Egr2 is also 
involved in apoptosis and mitochondrial functions 
via the regulation of Bcl-2 family proteins (Unoki 
and Nakamura, 2003; Lauritsen et al., 2008), and 
the involvement of dysregulation of the Bcl-2 family 
proteins or mitochondrial function in the patho-
genesis of BD has been suggested (Kato, 2006; 
Marmol, 2008; Andreazza et al., 2010; Kim et al., 
2010a).126    Exp. Mol. Med. Vol. 44(2), 121-129, 2012
    In  this  study,  no  association  was  found  with 
SPR. Recently, we reported the association of 
EGR3 with SPR in a case-control association study 
in Korea (Kim et al., 2010b), replicating a previous 
Japanese report (Yamada et al., 2007). However, 
two EGR2 SNPs (rs2295814 and rs2297488) did 
not show positive associations with SPR (Kim et 
al., 2010b), although they were associated with 
SPR in a Japanese family-based association 
analysis (Yamada et al., 2007). Additionally, in the 
current study, seven more examined EGR2 SNPs 
did not show associations with SPR. A recent 
case-control association study in a Han Chinese 
population also demonstrated that EGR2 did not 
show a significant association with SPR (Liu et al., 
2010). The possible association of EGR2 with SPR 
and the common and differential involvement of 
EGR genes, especially EGR2 and EGR3, require 
further clarification.
    As our study had a limited sample size, further 
extended analysis with a larger sample size or an 
independent replication study is required to confirm 
the positive association of EGR2  with BD. The 
strong association of EGR2  SNPs with BD, 
withstanding multiple testing corrections and a P 
value ＜0.001 (in the case of rs61865882), are 
noteworthy, and reduce the chance of this being a 
false-positive finding and predict future replication 
(Lohmueller  et al., 2003). Although the possible 
involvement of population stratification was not 
tested in this study, it seems unlikely in our sample 
because the Korean population is relatively homo-
geneous.
    In  conclusion,  we  found  a  genetic  association 
between EGR2 and BD in Korea. Of the nine SNPs 
of EGR2 examined, five showed nominal signifi-
cant allelic and genotypic associations with BD, 
and the positive association of four SNPs remained 
significant after multiple testing correction. 
Additionally, the corresponding haplotypes were 
found to be associated with BD. The human EGR2 
gene is located at chromosome 10q21, one of the 
loci related to the pathophysiology of BD. EGR2 
plays important roles in cognitive function, the 
myelination process, and intracellular signaling, 
making involvement in the pathogenesis of BD 
plausible. These findings suggest that the EGR2 
gene is related to the pathogenesis of BD.
Methods
Subjects
This study enrolled 946 individuals: 350 controls (174 men, 
176 women; mean age 25.9 ±6.5 years), 352 patients 
with BD (149 men, 203 women; average age 33.5 ±12.0 
years), and 244 patients with SPR (147 men, 97 women; 
average age 32.7 ±7.8 years). The participants were all 
ethnic Koreans. All patients met the Diagnostic and Statis-
tical Manual of Mental Disorders, 4
th edition (DSM-IV), cri-
teria for the diagnosis of BD or SPR. Patients were inter-
viewed individually by trained researchers using the 
Korean translation of the Diagnostic Interview for Genetic 
Studies (DIGS) (Joo et al., 2004). Meetings with at least 
two psychiatrists were held regularly to arrive at con-
sensual decisions about the participants’ final diagnoses 
and to eliminate subjects with organic brain disease, alco-
hol or drug problems, or other general medical conditions 
possibly manifesting as psychiatric symptoms. Healthy 
subjects included in the control group were recruited from 
hospital staff members and college students who vol-
unteered to participate. Interviews conducted by a psychia-
trist enabled the exclusion of subjects with histories or cur-
rent evidence of psychiatric illnesses, organic mental dis-
orders, substance abuse, or any medical conditions that 
might lead to mental symptoms. Control subjects who had 
any first-degree relatives with suspected psychiatric ill-
nesses were also excluded. All subjects in this study were 
unrelated. 
    The study protocol was approved by the ethics commit-
tee of Seoul National University Hospital, and this study 
was conducted in accordance with the latest version of the 
Declaration of Helsinki. Written informed consent was ob-
tained from each patient before enrollment, and only sub-
jects able to provide informed consent were included in the 
study.
SNPs selection and genotyping
Tag SNPs within the 15-kb region surrounding the EGR2 
gene (from 64237 to 64252 kb) were selected in the inter-
national HapMap database (Data release #27, http://hap-
map. ncbi.nlm.nih.gov/). Based on the close genetic back-
grounds of the Korean and Japanese populations (Kim et 
al., 2005; Tian et al., 2008), the genotypes downloaded 
were restricted to those of the Japanese population of 
Tokyo, Japan (JPT). Five tag SNPs (rs9990, rs1509963, 
rs2295814, rs10995315, and rs224278) with minor allele 
frequencies (MAF) above 10% and a minimum value of 0.8 
for the r
2 parameter were selected using the tagger algo-
rithm (de Bakker et al., 2005) implemented in Haploview 
(ver. 4.2) (Barrett et al., 2005). SNP rs2297488, which was 
included in previous studies of SPR in Japan (Yamada et 
al., 2007), Korea (Kim et al., 2010b), and China (Liu et al., 
2010) was included. Three additional EGR2 SNPs (rs6186-
5882, rs45602133, and rs2297489) with MAF above 10% 
in East Asian populations in the NCBI database 
(http://www.ncbi.nlm.nih.gov/projects/SNP/) were included 
in the analysis. SNP information, including the relative lo-
cation of the SNPs on the EGR2 gene, is presented in 
Figure 1. DNA was extracted from whole blood samples 
using a DNA isolation kit (Roche Applied Science, 
Indianapolis, IN). Genotyping assays were performed us-
ing the TaqMan method (Applied Biosystems, Foster City, 
CA), and high genotyping rates for all markers were 
achieved. The genotyping failure rates for all markers were 
less than 1% for the control, BD, and SPR groups. SNPs 
rs2295814 and rs2297488 in the control and SPR groups 
were genotyped in our previous study (Kim et al., 2010b), EGR2 and bipolar disorder    127
and are presented together with the current findings.
Statistical analyses
Contingency chi-square tests or Fisher's exact test were 
performed to compare allele and genotype frequencies be-
tween patients and controls. Correction for multiple testing 
was performed using a correction with 10,000 permuta-
tions with the Haploview software (ver. 4.2) and the 
Bonferroni correction. To avoid false-positive results due to 
multiple testing, we used the Bonferroni correction for the 
nine independent loci genotyped and for the comparisons 
of the control group with the SPR and BD groups. 
Significant P-values were changed to P=0.0028 (0.05/18). 
Haplotype frequencies and the significance of haplotype 
associations were calculated with Haploview. Rare hap-
lotypes were excluded from the analysis, while frequencies 
exceeding 5% were included for the analysis. Pair-wise LD 
statistics and HWE were also assessed with Haploview 
(ver. 4.2).
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